Latest On Natus Medical Incorporated (NTUS):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2022-05-25 21:13 EST | News | Natus Medical (NTUS) Investor presentations - Slideshow | N/A |  |
| 2022-05-06 05:46 EST | News | Natus Medical Non-GAAP EPS of $0.22, revenue of $119.8M | N/A | |
| 2022-04-18 18:35 EST | News | Natus Medical to be acquired by Archimed Group for $33.50/share in cash or $1.2B | N/A | |
| 2022-02-26 06:50 EST | News | Natus Medical Incorporated (NTUS) CEO Thomas Sullivan on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-02-25 11:59 EST | News | Natus Medical Incorporated 2021 Q4 - Results - Earnings Call Presentation | N/A | |
| 2022-02-24 16:22 EST | News | Natus Medical Non-GAAP EPS of $0.47 beats by $0.03, revenue of $128.7M beats by $2.9M | N/A | |
| 2022-01-10 23:20 EST | News | Natus Medical posts prelim. 2021 revenue ahead of consensus | N/A | |
| 2021-12-18 03:05 EST | News | Natus Medical appoints new CEO | N/A | |
| 2021-11-05 10:44 EST | News | Natus Medical EPS misses by $0.02, misses on revenue | N/A | |
| 2021-11-05 10:43 EST | News | Natus Medical Incorporated's (NTUS) CEO Jonathan Kennedy on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-09-27 22:43 EST | News | Natus Medical wins five-year DLA contract | N/A | |
| 2021-08-08 17:30 EST | News | Natus Medical's (NTUS) CEO Jonathan Kennedy on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2021-08-07 04:11 EST | News | Natus Medical Incorporated 2021 Q2 - Results - Earnings Call Presentation | N/A | |
| 2021-08-06 07:48 EST | News | Natus Medical EPS in-line, beats on revenue | N/A | |
| 2021-05-06 16:27 EST | News | Natus Medical EPS in-line, beats on revenue; provides outlook | N/A | |
| 2021-03-01 12:04 EST | Earnings Estimate | An EPS average of $1.48 is estimated for the 2022 year. | Buy | |
| 2021-03-01 12:04 EST | Earnings Estimate | An EPS average of $0.25 is estimated for the quarter ending on June 30, 2021. | Sell | |
| 2021-03-01 03:12 EST | News | Natus Medical Incorporated's (NTUS) CEO Jonathan Kennedy on Q4 2020 Results - Earnings Call Transcript | N/A | |
| 2021-02-27 04:09 EST | Financials | Company financials have been released. | Neutral | |
| 2021-02-26 04:46 EST | News | Natus Medical EPS beats by $0.15, beats on revenue | N/A | |
| 2021-01-08 20:38 EST | News | Natus Medical updates Q4 revenue guidance | N/A | |
| 2020-11-26 21:01 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-08 00:22 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 16:39 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-03 17:01 EST | Insider Trade | Austin Francis III Noll has directly acquired 686 shares and currently holds 93,704 shares. | Buy | |
| 2020-11-03 17:01 EST | Insider Trade | Jonathan Kennedy has directly acquired 686 shares and currently holds 162,285 shares. | Buy | |
| 2020-11-02 18:19 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-31 22:37 EST | News | Natus Medical EPS beats by $0.08, beats on revenue | N/A | |
| 2020-10-31 22:33 EST | News | Natus Medical Incorporated (NTUS) CEO Jonathan Kennedy on Q3 2020 Results - Earnings Call Transcript | N/A | |
| 2020-10-30 21:31 EST | Earnings Estimate | An EPS average of $0.15 is estimated for the quarter ending on March 31, 2021. | Buy | |
| 2020-09-26 13:34 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 05:40 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-01 13:17 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-28 21:17 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-25 01:25 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-21 17:41 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-14 09:38 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-10 17:04 EST | Insider Trade | Lisa Wipperman Heine has directly disposed of 1,200 shares and currently holds 15,998 shares. | Sell | |
| 2020-08-06 21:27 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 13:24 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-02 20:41 EST | News | Natus Medical Incorporated (NTUS) CEO Jonathan Kennedy on Q2 2020 Results - Earnings Call Transcript | N/A | |
| 2020-08-02 18:20 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-31 02:32 EST | News | Natus Medical EPS beats by $0.08, misses on revenue | N/A | |
| 2020-07-31 01:51 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 17:20 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 05:19 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-27 13:16 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 17:55 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-09 09:31 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 17:19 EST | Financials | Company financials have been released. | Neutral | |
About Natus Medical Incorporated (NTUS):
Natus Medical Incorporated provides medical device solutions focusing on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide. It offers products and services used for the screening, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological and neurosurgical treatments, epilepsy, sleep disorders, and neuromuscular diseases. The company also provides computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories. In addition, it offers electroencephalography, long term monitoring, intensive care unit monitoring, electromyography, sleep analysis or polysomnography, and intra-operative monitoring solutions. Further, the company provides hearing assessment, screening, and instrument fitting solutions; jaundice management products; brain injury products; and eye imaging systems and products used in the advanced science and practice of neonatal and pediatric retinal imaging. Additionally, it offers NICVIEW, a live streaming video for families with babies in the neonatal intensive care unit (NICU); essential products used in the everyday operation of NICU; balance assessment systems to evaluate patients with balance disorders. The company also provides computer-based audiological, otoneurologic, and vestibular instrumentation for hearing and balance care professionals. It serves university medical centers, public and private hospitals, physician offices, clinics, research laboratories, and others. The company was founded in 1987 and is headquartered in Pleasanton, California.
General
- Name Natus Medical Incorporated
- Symbol NTUS
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryMedical Devices
- Full Time Employees 1,420
- Fiscal Year EndDecember
- IPO Date2001-07-31
- Gic SectorHealth Care
- Gic GroupHealth Care Equipment & Services
- Gic IndustryHealth Care Equipment & Supplies
- Gic SubIndustryHealth Care Equipment
- Web URLhttp://www.natus.com
View More
Valuation
- Trailing PE 65.28
- Price/Sales (Trailing 12 Mt.) 2.15
- Price/Book (Most Recent Quarter) 2.19
- Enterprise Value Revenue 2.14
- Enterprise Value EBITDA 91.69
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate $1.18
- Next Year EPS Estimate $1.48
- Next Quarter EPS Estimate $0.16
- Profit Margin -4%
- Operating Margin -2%
- Return on Assets -1%
- Return on Equity -4%
- Revenue 415.68 million
- Earnings Per Share -$1.29
- Revenue Per Share $12.39
- Gross Profit 236.17 million
- Quarterly Earnings Growth -9.7%
View More
Highlights
- Market Capitalization 926.8 million
- EBITDA 18.17 million
- Analyst Target Price $36
- Book Value Per Share $12.40
View More
Share Statistics
- Shares Outstanding 33.87 million
- Shares Float 32.82 million
- % Held by Insiders 172%
- % Held by Institutions 95.37%
- Shares Short 728005
- Shares Short Prior Month 830593
- Short Ratio 4.15
- Short % of Float 3%
- Short % of Shares Outstanding 2%
View More
Technicals
- Beta 0.56
- 52 Week High $27.97
- 52 Week Low $16.38
- 50 Day Moving Average 26
- 200 Day Moving Average 21.57
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Natus Medical Incorporated (NTUS) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Natus Medical Incorporated (NTUS) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-02-25 | $N/A | $0.39 | $0.24 | 62.5% |
| 2020-09-30 | 2020-10-29 | $102.8 million | $0.09 | $0.01 | 800% |
| 2020-06-30 | 2020-07-30 | $N/A | -$0.13 | $0.05 | -360% |
| 2020-03-31 | 2020-04-30 | $N/A | $0.04 | $0.22 | -81.82% |
| 2019-12-31 | 2020-02-06 | $131.76 million | $0.46 | $0.47 | -2.13% |
| 2019-09-30 | 2019-10-24 | $123.46 million | $0.36 | $0.38 | -4% |
| 2019-06-30 | 2019-07-25 | $125.54 million | $0.34 | $0.30 | 13.33% |
| 2019-03-31 | 2019-04-25 | $114.76 million | $0.09 | $0.06 | 63.64% |
| 2018-12-31 | 2019-02-13 | $140.99 million | $0.43 | $0.49 | -12.24% |
| 2018-09-30 | 2018-10-24 | $130.64 million | $0.40 | $0.42 | -5.5% |
| 2018-06-30 | 2018-07-25 | $0.35 | $0.26 | 32.93% | |
| 2018-03-31 | 2018-04-25 | $0.24 | $0.24 | 1.39% | |
| 2017-12-31 | 2018-02-07 | $0.42 | $0.54 | -22.22% | |
| 2017-09-30 | 2017-10-25 | $0.40 | $0.38 | 6.19% | |
| 2017-06-30 | 2017-07-26 | $0.34 | $0.33 | 4.62% | |
| 2017-03-31 | 2017-04-26 | $0.30 | $0.33 | -7.69% | |
| 2016-12-31 | 2017-02-01 | $0.51 | $0.53 | -2.86% | |
| 2016-09-30 | 2016-10-19 | $0.39 | $0.33 | 17.01% | |
| 2016-06-30 | 2016-07-20 | $0.39 | $0.36 | 9.34% | |
| 2016-03-31 | 2016-04-20 | $87.33 million | $0.34 | $0.30 | 14.59% |
| 2015-12-31 | 2016-01-27 | $0.51 | $0.46 | 10.87% | |
| 2015-09-30 | 2015-10-21 | $94.58 million | $0.39 | $0.38 | 2.63% |
| 2015-06-30 | 2015-07-22 | $91.94 million | $0.34 | $0.32 | 6.25% |
| 2015-03-31 | 2015-04-22 | $89.4 million | $0.31 | $0.29 | 6.9% |
| 2014-12-31 | 2015-01-28 | $0.40 | $0.39 | 2.56% | |
| 2014-09-30 | 2014-10-22 | $89.88 million | $0.33 | $0.31 | 6.45% |
| 2014-06-30 | 2014-07-23 | $86.33 million | $0.28 | $0.26 | 7.69% |
| 2014-03-31 | 2014-04-23 | $85.62 million | $0.26 | $0.23 | 13.04% |
| 2013-12-31 | 2014-01-29 | $0.37 | $0.32 | 15.63% | |
| 2013-09-30 | 2013-10-24 | $85.39 million | $0.30 | $0.19 | 57.89% |
| 2013-06-30 | 2013-08-01 | $82.25 million | $0.21 | $0.14 | 50% |
| 2013-03-31 | 2013-05-20 | $85.83 million | $0.15 | $0.11 | 36.36% |
| 2012-12-31 | 2013-02-28 | $0.29 | $0.26 | 11.54% | |
| 2012-09-30 | 2012-11-07 | $0.15 | $0.13 | 15.38% | |
| 2012-06-30 | 2012-07-26 | $0.12 | $0.12 | 0% | |
| 2012-03-31 | 2012-04-26 | $0.07 | $0.05 | 40% | |
| 2011-12-31 | 2012-02-28 | $0.14 | $0.15 | -6.67% | |
| 2011-09-30 | 2011-10-27 | $0.07 | $0.07 | 0% | |
| 2011-06-30 | 2011-07-28 | $0.13 | $0.13 | 0% | |
| 2011-03-31 | 2011-04-28 | $0.13 | $0.11 | 18.18% | |
| 2010-12-31 | 2011-03-01 | $0.24 | $0.21 | 14.29% | |
| 2010-09-30 | 2010-10-28 | $0.17 | $0.19 | -10.53% | |
| 2010-06-30 | 2010-07-29 | $0.15 | $0.14 | 7.14% | |
| 2010-03-31 | 2010-04-29 | $0.09 | $0.03 | 200% | |
| 2009-12-31 | 2010-03-04 | $0.15 | $0.15 | 0% | |
| 2009-09-30 | 2009-11-02 | $0.13 | $0.11 | 18.18% | |
| 2009-06-30 | 2009-07-30 | $0.08 | $0.05 | 60% | |
| 2009-03-31 | 2009-04-30 | $0.03 | $0.02 | 50% | |
| 2008-12-31 | 2009-02-26 | $0.22 | $0.21 | 4.76% | |
| 2008-09-30 | 2008-10-30 | $0.17 | $0.18 | -5.56% | |
| 2008-06-30 | 2008-07-31 | $0.15 | $0.14 | 7.14% | |
| 2008-03-31 | 2008-05-01 | $0.11 | $0.10 | 10% | |
| 2007-12-31 | 2008-02-26 | $0.17 | $0.18 | -5.56% | |
| 2007-09-30 | 2007-11-01 | $0.14 | $0.13 | 7.69% | |
| 2007-06-30 | 2007-08-02 | $0.10 | $0.10 | 0% | |
| 2007-03-31 | 2007-05-03 | $0.07 | $0.08 | -12.5% | |
| 2006-12-31 | 2007-02-20 | $0.13 | $0.12 | 8.33% | |
| 2006-09-30 | 2006-11-01 | $0.09 | $0.08 | 12.5% | |
| 2006-06-30 | 2006-08-02 | $0.07 | $0.06 | 16.67% | |
| 2006-03-31 | 2006-05-02 | $0.07 | $0.08 | -12.5% | |
| 2005-12-31 | 2006-02-21 | $0.13 | $0.11 | 18.18% | |
| 2005-09-30 | 2005-10-26 | $0.08 | $0.08 | 0% | |
| 2005-06-30 | 2005-07-28 | $0.07 | $0.06 | 16.67% | |
| 2005-03-31 | 2005-05-05 | $0.05 | $0.03 | 66.67% | |
| 2004-12-31 | 2005-02-25 | $0.08 | $0.07 | 14.29% | |
| 2004-09-30 | 2004-11-09 | $0.06 | $0.03 | 100% | |
| 2004-06-30 | 2004-08-10 | -$0.08 | -$0.01 | -700% | |
| 2004-03-31 | 2004-05-13 | -$0.03 | |||
| 2003-12-31 | 2004-02-27 | $0.02 | |||
| 2003-09-30 | 2003-11-13 | -$0.06 | |||
| 2003-06-30 | 2003-08-08 | -$0.07 | |||
| 2003-03-31 | 2003-05-06 | -$0.06 | -$0.07 | 14.29% | |
| 2002-12-31 | 2003-02-19 | -$0.11 | -$0.01 | -1000% | |
| 2002-09-30 | 2002-11-05 | -$0.10 | -$0.13 | 23.08% | |
| 2002-06-30 | 2002-08-06 | -$0.12 | -$0.08 | -50% | |
| 2002-03-31 | 2002-04-29 | -$0.11 | -$0.08 | -37.5% | |
| 2001-12-31 | 2002-02-07 | -$0.08 | -$0.05 | -60% | |
| 2001-09-30 | 2001-11-06 | -$0.06 | -$0.07 | 14.29% |
Natus Medical Incorporated (NTUS) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Natus Medical Incorporated (NTUS) Chart:
Natus Medical Incorporated (NTUS) News:
Below you will find a list of latest news for Natus Medical Incorporated (NTUS) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Natus Medical Incorporated (NTUS) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Latest NTUS Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 100 | $32.51 |
| Jun 13, 2022 7:59 PM EST | 100 | $32.51 |
| Jun 13, 2022 7:59 PM EST | 7 | $32.5 |
| Jun 13, 2022 7:59 PM EST | 15 | $32.52 |
| Jun 13, 2022 7:59 PM EST | 4 | $32.5 |
Natus Medical Incorporated (NTUS) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852620000069/0000878526-20-000069-index.htm |
| 2018-07-30 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/878526/000000000018023249/0000000000-18-023249-index.htm |
| 2019-01-31 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/878526/000021545719002336/0000215457-19-002336-index.htm |
| 2020-02-04 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/878526/000083423720002066/0000834237-20-002066-index.htm |
| 2018-07-20 | 10-K/A | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/878526/000087852618000125/0000878526-18-000125-index.htm |
| 2018-07-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/878526/000087852618000128/0000878526-18-000128-index.htm |
| 2018-07-26 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852618000130/0000878526-18-000130-index.htm |
| 2018-07-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852618000132/0000878526-18-000132-index.htm |
| 2018-08-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852618000134/0000878526-18-000134-index.htm |
| 2018-08-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/878526/000087852618000138/0000878526-18-000138-index.htm |
| 2018-08-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/878526/000087852618000140/0000878526-18-000140-index.htm |
| 2018-08-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852618000142/0000878526-18-000142-index.htm |
| 2018-08-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852618000144/0000878526-18-000144-index.htm |
| 2018-09-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/878526/000087852618000146/0000878526-18-000146-index.htm |
| 2018-10-03 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852618000148/0000878526-18-000148-index.htm |
| 2018-10-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852618000150/0000878526-18-000150-index.htm |
| 2018-10-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/878526/000087852618000154/0000878526-18-000154-index.htm |
| 2018-11-02 | DEFC14A | Definitive proxy statement, contested solicitations | https://www.sec.gov/Archives/edgar/data/878526/000087852618000156/0000878526-18-000156-index.htm |
| 2018-11-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/878526/000087852618000161/0000878526-18-000161-index.htm |
| 2018-11-09 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/878526/000087852618000163/0000878526-18-000163-index.htm |
| 2018-11-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852618000165/0000878526-18-000165-index.htm |
| 2018-11-26 | DEFR14A | Revised definitive proxy soliciting materials | https://www.sec.gov/Archives/edgar/data/878526/000087852618000167/0000878526-18-000167-index.htm |
| 2018-12-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852618000169/0000878526-18-000169-index.htm |
| 2018-12-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/878526/000087852618000172/0000878526-18-000172-index.htm |
| 2018-12-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/878526/000087852618000174/0000878526-18-000174-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852619000004/0000878526-19-000004-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852619000005/0000878526-19-000005-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852619000006/0000878526-19-000006-index.htm |
| 2019-01-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/878526/000087852619000008/0000878526-19-000008-index.htm |
| 2019-01-22 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/878526/000087852619000013/0000878526-19-000013-index.htm |
| 2019-01-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852619000015/0000878526-19-000015-index.htm |
| 2019-01-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852619000017/0000878526-19-000017-index.htm |
| 2019-01-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852619000019/0000878526-19-000019-index.htm |
| 2019-01-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852619000022/0000878526-19-000022-index.htm |
| 2019-02-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/878526/000087852619000026/0000878526-19-000026-index.htm |
| 2019-02-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/878526/000087852619000029/0000878526-19-000029-index.htm |
| 2019-02-13 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852619000032/0000878526-19-000032-index.htm |
| 2019-02-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852619000034/0000878526-19-000034-index.htm |
| 2019-02-14 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852619000036/0000878526-19-000036-index.htm |
| 2019-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852619000038/0000878526-19-000038-index.htm |
| 2019-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852619000040/0000878526-19-000040-index.htm |
| 2019-03-01 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/878526/000087852619000045/0000878526-19-000045-index.htm |
| 2019-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852619000047/0000878526-19-000047-index.htm |
| 2019-03-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852619000049/0000878526-19-000049-index.htm |
| 2019-03-15 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/878526/000087852619000052/0000878526-19-000052-index.htm |
| 2019-04-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/878526/000087852619000054/0000878526-19-000054-index.htm |
| 2019-04-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/878526/000087852619000056/0000878526-19-000056-index.htm |
| 2019-04-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/878526/000087852619000061/0000878526-19-000061-index.htm |
| 2019-05-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852619000063/0000878526-19-000063-index.htm |
| 2019-05-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852619000065/0000878526-19-000065-index.htm |
| 2019-05-06 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/878526/000087852619000070/0000878526-19-000070-index.htm |
| 2019-05-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/878526/000087852619000074/0000878526-19-000074-index.htm |
| 2019-05-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852619000076/0000878526-19-000076-index.htm |
| 2019-05-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852619000078/0000878526-19-000078-index.htm |
| 2019-05-31 | SD | https://www.sec.gov/Archives/edgar/data/878526/000087852619000081/0000878526-19-000081-index.htm | |
| 2019-06-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852619000083/0000878526-19-000083-index.htm |
| 2019-06-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/878526/000087852619000090/0000878526-19-000090-index.htm |
| 2019-06-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852619000092/0000878526-19-000092-index.htm |
| 2019-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852619000094/0000878526-19-000094-index.htm |
| 2019-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852619000096/0000878526-19-000096-index.htm |
| 2019-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852619000098/0000878526-19-000098-index.htm |
| 2019-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852619000100/0000878526-19-000100-index.htm |
| 2019-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852619000102/0000878526-19-000102-index.htm |
| 2019-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852619000104/0000878526-19-000104-index.htm |
| 2019-07-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/878526/000087852619000111/0000878526-19-000111-index.htm |
| 2019-07-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/878526/000087852619000113/0000878526-19-000113-index.htm |
| 2019-08-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852619000116/0000878526-19-000116-index.htm |
| 2019-08-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852619000118/0000878526-19-000118-index.htm |
| 2019-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/878526/000087852619000122/0000878526-19-000122-index.htm |
| 2019-10-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/878526/000087852619000125/0000878526-19-000125-index.htm |
| 2019-11-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852619000127/0000878526-19-000127-index.htm |
| 2019-11-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852619000129/0000878526-19-000129-index.htm |
| 2019-11-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/878526/000087852619000132/0000878526-19-000132-index.htm |
| 2019-11-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852619000134/0000878526-19-000134-index.htm |
| 2019-12-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852619000136/0000878526-19-000136-index.htm |
| 2019-12-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/878526/000087852619000143/0000878526-19-000143-index.htm |
| 2019-12-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/878526/000087852619000147/0000878526-19-000147-index.htm |
| 2020-01-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852620000002/0000878526-20-000002-index.htm |
| 2020-01-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852620000004/0000878526-20-000004-index.htm |
| 2020-01-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852620000006/0000878526-20-000006-index.htm |
| 2020-01-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852620000008/0000878526-20-000008-index.htm |
| 2020-01-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/878526/000087852620000010/0000878526-20-000010-index.htm |
| 2020-01-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852620000012/0000878526-20-000012-index.htm |
| 2020-02-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/878526/000087852620000015/0000878526-20-000015-index.htm |
| 2020-03-02 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/878526/000087852620000022/0000878526-20-000022-index.htm |
| 2020-03-02 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/878526/000087852620000023/0000878526-20-000023-index.htm |
| 2020-03-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/878526/000087852620000030/0000878526-20-000030-index.htm |
| 2020-03-20 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852620000033/0000878526-20-000033-index.htm |
| 2020-03-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852620000034/0000878526-20-000034-index.htm |
| 2020-04-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/878526/000087852620000037/0000878526-20-000037-index.htm |
| 2020-04-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/878526/000087852620000042/0000878526-20-000042-index.htm |
| 2020-05-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/878526/000087852620000044/0000878526-20-000044-index.htm |
| 2020-05-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/878526/000087852620000047/0000878526-20-000047-index.htm |
| 2020-05-29 | SD | https://www.sec.gov/Archives/edgar/data/878526/000087852620000051/0000878526-20-000051-index.htm | |
| 2020-06-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/878526/000087852620000057/0000878526-20-000057-index.htm |
| 2020-06-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852620000059/0000878526-20-000059-index.htm |
| 2020-06-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852620000061/0000878526-20-000061-index.htm |
| 2020-06-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852620000063/0000878526-20-000063-index.htm |
| 2020-06-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852620000065/0000878526-20-000065-index.htm |
| 2020-06-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852620000067/0000878526-20-000067-index.htm |
| 2020-06-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852620000069/0000878526-20-000069-index.htm |
| 2020-07-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/878526/000087852620000074/0000878526-20-000074-index.htm |
| 2020-08-04 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/878526/000087852620000077/0000878526-20-000077-index.htm |
| 2020-08-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852620000079/0000878526-20-000079-index.htm |
| 2020-08-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/878526/000087852620000083/0000878526-20-000083-index.htm |
| 2020-10-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852620000085/0000878526-20-000085-index.htm |
| 2020-10-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/878526/000087852620000089/0000878526-20-000089-index.htm |
| 2020-11-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852620000092/0000878526-20-000092-index.htm |
| 2020-11-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/878526/000087852620000094/0000878526-20-000094-index.htm |
| 2020-11-04 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/878526/000087852620000098/0000878526-20-000098-index.htm |
| 2019-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/878526/000090221919000341/0000902219-19-000341-index.htm |
| 2019-02-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/878526/000093247119005444/0000932471-19-005444-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/878526/000110465920018311/0001104659-20-018311-index.htm |
| 2019-04-05 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/878526/000114036119006597/0001140361-19-006597-index.htm |
| 2019-04-15 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/878526/000114036119007102/0001140361-19-007102-index.htm |
| 2019-04-17 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/878526/000114036119007261/0001140361-19-007261-index.htm |
| 2020-05-08 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/878526/000114036120011079/0001140361-20-011079-index.htm |
| 2020-05-08 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/878526/000114036120011082/0001140361-20-011082-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/878526/000119312519039325/0001193125-19-039325-index.htm |
| 2019-02-08 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/878526/000125889719001528/0001258897-19-001528-index.htm |
| 2019-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/878526/000127417319000062/0001274173-19-000062-index.htm |
| 2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/878526/000127417320000038/0001274173-20-000038-index.htm |
Natus Medical Incorporated (NTUS) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Natus Medical Incorporated (NTUS). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 172%Institutional Ownership: 9537%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2019-07-01 | Lisa Wipperman Heine | Director | Buy | 5,846.00 | 25.66 | 150,008.36 | 10,078.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852619000094/0000878526-19-000094-index.htm |
| 2019-07-31 | Austin Francis III Noll | Executive VP and CCO | Buy | 20,000.00 | 22.50 | 450,000.00 | 105,193.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852619000116/0000878526-19-000116-index.htm |
| 2020-06-19 | Ilan Daskal | Director | Buy | 3,560.00 | 21.07 | 75,009.20 | 11,148.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852620000069/0000878526-20-000069-index.htm |
| 2018-08-30 | Jonathan Kennedy | President and CEO | Sell | 4,072.00 | 36.54 | 148,790.88 | 114,028.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852618000144/0000878526-18-000144-index.htm |
| 2018-08-29 | Jonathan Kennedy | President and CEO | Sell | 12,183.00 | 36.96 | 450,283.68 | 118,100.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852618000144/0000878526-18-000144-index.htm |
| 2018-08-24 | Jonathan Kennedy | President and CEO | Buy | 22,695.00 | 35.25 | 799,998.75 | 130,283.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852618000142/0000878526-18-000142-index.htm |
| 2018-08-29 | Jonathan Kennedy | President and CEO | Sell | 31,345.00 | 36.85 | 1,155,063.25 | 130,283.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852618000144/0000878526-18-000144-index.htm |
| 2019-01-17 | DONG CHUNE CHRISTOPHER CHUNG | VP of Medical Affairs | Buy | 6,694.00 | 33.61 | 224,985.34 | 138,398.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852619000015/0000878526-19-000015-index.htm |
| 2019-01-23 | Jonathan Kennedy | President and CEO | Buy | 40,572.00 | 33.89 | 1,374,985.08 | 139,517.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852619000022/0000878526-19-000022-index.htm |
| 2019-11-04 | Jonathan Kennedy | President and CEO | Sell | 4,408.00 | 33.65 | 148,329.20 | 140,109.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852619000134/0000878526-19-000134-index.htm |
| 2019-11-05 | Jonathan Kennedy | President and CEO | Sell | 4,268.00 | 34.32 | 146,477.76 | 140,841.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852619000134/0000878526-19-000134-index.htm |
| 2019-12-06 | Jonathan Kennedy | President and CEO | Sell | 6,684.00 | 31.54 | 210,813.36 | 141,757.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852619000136/0000878526-19-000136-index.htm |
| 2019-11-04 | Jonathan Kennedy | President and CEO | Buy | 5,000.00 | 22.50 | 112,500.00 | 144,517.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852619000134/0000878526-19-000134-index.htm |
| 2019-11-05 | Jonathan Kennedy | President and CEO | Buy | 5,000.00 | 22.50 | 112,500.00 | 145,109.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852619000134/0000878526-19-000134-index.htm |
| 2019-12-06 | Jonathan Kennedy | President and CEO | Buy | 7,600.00 | 22.50 | 171,000.00 | 148,441.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852619000136/0000878526-19-000136-index.htm |
| 2020-06-19 | ALICE D. SCHROEDER | Director | Buy | 7,120.00 | 21.07 | 150,018.40 | 15,051.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852620000065/0000878526-20-000065-index.htm |
| 2020-06-19 | Thomas Joseph Sullivan | Director | Buy | 7,120.00 | 21.07 | 150,018.40 | 15,051.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852620000067/0000878526-20-000067-index.htm |
| 2019-05-21 | DONG CHUNE CHRISTOPHER CHUNG | VP of Medical Affairs | Sell | 500.00 | 26.64 | 13,320.00 | 150,898.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852619000078/0000878526-19-000078-index.htm |
| 2019-10-30 | DONG CHUNE CHRISTOPHER CHUNG | VP of Medical Affairs | Sell | 14,000.00 | 33.57 | 469,980.00 | 150,898.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852619000127/0000878526-19-000127-index.htm |
| 2019-05-17 | DONG CHUNE CHRISTOPHER CHUNG | VP of Medical Affairs | Sell | 3,000.00 | 26.28 | 78,840.00 | 151,398.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852619000078/0000878526-19-000078-index.htm |
| 2019-05-17 | DONG CHUNE CHRISTOPHER CHUNG | VP of Medical Affairs | Buy | 16,000.00 | 14.34 | 229,440.00 | 154,398.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852619000078/0000878526-19-000078-index.htm |
| 2020-01-02 | DONG CHUNE CHRISTOPHER CHUNG | VP of Medical Affairs | Buy | 10,334.00 | 32.66 | 337,508.44 | 154,881.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852620000002/0000878526-20-000002-index.htm |
| 2020-08-07 | Lisa Wipperman Heine | Director | Sell | 1,200.00 | 18.03 | 21,636.00 | 15,998.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852620000079/0000878526-20-000079-index.htm |
| 2020-01-10 | Jonathan Kennedy | President and CEO | Buy | 42,101.00 | 32.66 | 1,375,018.66 | 161,599.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852620000012/0000878526-20-000012-index.htm |
| 2018-08-29 | Jonathan Kennedy | President and CEO | Buy | 31,345.00 | 13.24 | 415,007.80 | 161,628.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852618000144/0000878526-18-000144-index.htm |
| 2020-10-30 | Jonathan Kennedy | President and CEO | Buy | 686.00 | 15.48 | 10,619.28 | 162,285.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852620000094/0000878526-20-000094-index.htm |
| 2019-10-30 | DONG CHUNE CHRISTOPHER CHUNG | VP of Medical Affairs | Buy | 14,000.00 | 22.50 | 315,000.00 | 164,898.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852619000127/0000878526-19-000127-index.htm |
| 2020-06-19 | Lisa Wipperman Heine | Director | Buy | 7,120.00 | 21.07 | 150,018.40 | 17,198.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852620000063/0000878526-20-000063-index.htm |
| 2019-07-01 | BARBARA R PAUL | Director | Buy | 5,846.00 | 25.66 | 150,008.36 | 17,438.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852619000100/0000878526-19-000100-index.htm |
| 2019-07-01 | JOSHUA LEVINE | Director | Buy | 5,846.00 | 25.66 | 150,008.36 | 19,978.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852619000096/0000878526-19-000096-index.htm |
| 2019-05-02 | ROBERT A GUNST | Director | Sell | 2,000.00 | 26.92 | 53,840.00 | 20,392.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852619000065/0000878526-19-000065-index.htm |
| 2019-05-01 | ROBERT A GUNST | Director | Sell | 4,000.00 | 26.88 | 107,520.00 | 22,392.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852619000065/0000878526-19-000065-index.htm |
| 2018-10-01 | Benjamin Drew Davies | Sr. VP, CFO | Buy | 23,845.00 | 35.65 | 850,074.25 | 23,845.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852618000150/0000878526-18-000150-index.htm |
| 2020-06-19 | BARBARA R PAUL | Director | Buy | 7,120.00 | 21.07 | 150,018.40 | 24,558.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852620000059/0000878526-20-000059-index.htm |
| 2019-04-30 | ROBERT A GUNST | Director | Sell | 2,000.00 | 26.25 | 52,500.00 | 26,392.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852619000065/0000878526-19-000065-index.htm |
| 2020-06-19 | JOSHUA LEVINE | Director | Buy | 7,120.00 | 21.07 | 150,018.40 | 27,098.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852620000061/0000878526-20-000061-index.htm |
| 2019-03-04 | ROBERT A GUNST | Director | Sell | 2,000.00 | 28.50 | 57,000.00 | 28,392.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852619000047/0000878526-19-000047-index.htm |
| 2019-03-01 | ROBERT A GUNST | Director | Sell | 2,000.00 | 28.30 | 56,600.00 | 30,392.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852619000047/0000878526-19-000047-index.htm |
| 2018-11-19 | ROBERT A GUNST | Director | Sell | 14,750.00 | 33.54 | 494,715.00 | 32,392.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852618000165/0000878526-18-000165-index.htm |
| 2019-03-01 | ROBERT A GUNST | Director | Sell | 4,304.00 | 27.80 | 119,651.20 | 32,392.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852619000047/0000878526-19-000047-index.htm |
| 2019-02-25 | ROBERT A GUNST | Director | Sell | 3,696.00 | 28.34 | 104,744.64 | 36,696.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852619000040/0000878526-19-000040-index.htm |
| 2019-02-22 | ROBERT A GUNST | Director | Buy | 5,000.00 | 14.34 | 71,700.00 | 37,392.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852619000040/0000878526-19-000040-index.htm |
| 2019-08-01 | KEN LUDLUM | Director | Sell | 12,632.00 | 31.94 | 403,466.08 | 39,406.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852619000118/0000878526-19-000118-index.htm |
| 2019-02-22 | ROBERT A GUNST | Director | Buy | 3,000.00 | 24.50 | 73,500.00 | 40,392.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852619000040/0000878526-19-000040-index.htm |
| 2019-03-07 | Lisa Wipperman Heine | Director | Buy | 100.00 | 27.18 | 2,718.00 | 4,232.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852619000049/0000878526-19-000049-index.htm |
| 2019-06-11 | KEN LUDLUM | Director | Sell | 4,250.00 | 24.41 | 103,742.50 | 46,192.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852619000092/0000878526-19-000092-index.htm |
| 2020-01-02 | Benjamin Drew Davies | Executive VP and CFO | Buy | 13,013.00 | 32.66 | 425,004.58 | 46,960.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852620000006/0000878526-20-000006-index.htm |
| 2018-07-31 | ROBERT A GUNST | Director | Sell | 500.00 | 36.05 | 18,025.00 | 47,142.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852618000132/0000878526-18-000132-index.htm |
| 2018-07-31 | ROBERT A GUNST | Director | Sell | 3,240.00 | 36.00 | 116,640.00 | 47,642.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852618000132/0000878526-18-000132-index.htm |
| 2018-10-01 | Benjamin Drew Davies | Sr. VP, CFO | Buy | 23,845.00 | 0.00 | 23.85 | 47,690.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852618000150/0000878526-18-000150-index.htm |
| 2019-02-11 | ALICE D. SCHROEDER | Director | Buy | 5,008.00 | 29.95 | 149,989.60 | 5,008.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852619000034/0000878526-19-000034-index.htm |
| 2019-02-11 | Thomas Joseph Sullivan | Director | Buy | 5,008.00 | 29.95 | 149,989.60 | 5,008.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852619000038/0000878526-19-000038-index.htm |
| 2019-05-31 | KEN LUDLUM | Director | Sell | 6,000.00 | 24.84 | 149,040.00 | 50,442.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852619000083/0000878526-19-000083-index.htm |
| 2018-07-27 | ROBERT A GUNST | Director | Sell | 4,100.00 | 34.03 | 139,523.00 | 50,882.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852618000132/0000878526-18-000132-index.htm |
| 2019-07-01 | KEN LUDLUM | Director | Buy | 5,846.00 | 25.66 | 150,008.36 | 52,038.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852619000098/0000878526-19-000098-index.htm |
| 2018-07-27 | ROBERT A GUNST | Director | Sell | 5,000.00 | 34.17 | 170,850.00 | 54,982.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852618000132/0000878526-18-000132-index.htm |
| 2019-05-10 | KEN LUDLUM | Director | Sell | 7,515.00 | 26.28 | 197,494.20 | 56,442.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852619000076/0000878526-19-000076-index.htm |
| 2019-01-17 | Benjamin Drew Davies | Executive VP and CFO | Buy | 14,877.00 | 33.61 | 500,015.97 | 62,567.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852619000019/0000878526-19-000019-index.htm |
| 2018-11-29 | KEN LUDLUM | Director | Sell | 10,000.00 | 34.93 | 349,300.00 | 63,957.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852618000169/0000878526-18-000169-index.htm |
| 2018-10-26 | KEN LUDLUM | Director | Sell | 20,000.00 | 29.06 | 581,200.00 | 73,957.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852618000169/0000878526-18-000169-index.htm |
| 2020-03-18 | Ilan Daskal | Director | Buy | 7,588.00 | 19.77 | 150,014.76 | 7,588.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852620000034/0000878526-20-000034-index.htm |
| 2019-07-01 | ALICE D. SCHROEDER | Director | Buy | 2,923.00 | 25.66 | 75,004.18 | 7,931.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852619000102/0000878526-19-000102-index.htm |
| 2019-07-01 | Thomas Joseph Sullivan | Director | Buy | 2,923.00 | 25.66 | 75,004.18 | 7,931.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852619000104/0000878526-19-000104-index.htm |
| 2019-01-17 | Austin Francis III Noll | Executive VP and CCO | Buy | 10,414.00 | 33.61 | 350,014.54 | 85,193.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852619000017/0000878526-19-000017-index.htm |
| 2019-04-30 | Austin Francis III Noll | Executive VP and CCO | Sell | 14,250.00 | 26.43 | 376,627.50 | 85,193.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852619000063/0000878526-19-000063-index.htm |
| 2019-07-31 | Austin Francis III Noll | Executive VP and CCO | Sell | 20,000.00 | 31.14 | 622,800.00 | 85,193.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852619000116/0000878526-19-000116-index.htm |
| 2020-01-02 | Austin Francis III Noll | Executive VP and CCO | Buy | 16,075.00 | 32.66 | 525,009.50 | 93,018.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852620000004/0000878526-20-000004-index.htm |
| 2020-10-30 | Austin Francis III Noll | Executive VP and CCO | Buy | 686.00 | 15.48 | 10,619.28 | 93,704.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852620000092/0000878526-20-000092-index.htm |
| 2018-08-02 | KEN LUDLUM | Director | Sell | 5,000.00 | 36.89 | 184,450.00 | 93,957.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852618000134/0000878526-18-000134-index.htm |
| 2018-08-02 | KEN LUDLUM | Director | Buy | 3,000.00 | 24.50 | 73,500.00 | 96,957.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852618000134/0000878526-18-000134-index.htm |
| 2018-08-02 | KEN LUDLUM | Director | Buy | 5,000.00 | 14.34 | 71,700.00 | 98,957.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852618000134/0000878526-18-000134-index.htm |
| 2019-04-30 | Austin Francis III Noll | Executive VP and CCO | Buy | 14,250.00 | 14.34 | 204,345.00 | 99,443.00 | https://www.sec.gov/Archives/edgar/data/878526/000087852619000063/0000878526-19-000063-index.htm |